Search results for "Cardiac"

showing 10 items of 1495 documents

Deliberate Arterial Hypotension Does Not Reduce Intraocular Pressure in Pigs

1992

Among the accepted advantages of general anesthesia in ophthalmic surgery is improved control of intraocular pressure (IOP). Although standard textbooks advocate deliberate arterial hypotension to facilitate intraocular surgery by reducing IOP, scientific proof of such an effect is lacking. The authors investigated effects of induced arterial hypotension on IOP in an anesthetized porcine model. Forty-two piglets were anesthetized with piritramide, were placed in the prone position, and had the anterior chamber of one eye punctured with a small Teflon cannula to measure IOP. Six pigs were used in a pilot study to establish dose-response relationships for the hypotensive agents; 36 pigs were …

NitroprussideIntraocular pressureMean arterial pressureAdenosineIntracranial Pressuregenetic structuresSwineCardiac indexHemodynamicsHypotension ControlledPiritramidemedicineAnimalsIntraocular PressureIntracranial pressureIsofluranePulmonary Gas Exchangebusiness.industryHemodynamicsCannulaeye diseasesAnesthesiology and Pain MedicineIsofluraneAnesthesiasense organsbusinessmedicine.drugAnesthesiology
researchProduct

Spectrum of non-cardiac collateral findings in patients with suspected coronary artery disease assessed with Multislice Computed Tomography Coronary …

2009

Non-cardiac collateral findingSettore MED/36 - Diagnostica Per Immagini E RadioterapiaMultislice Computed Tomography Coronary Angiography.coronary artery disease
researchProduct

Contrast-Enhanced Magnetic Resonance Angiography of the Pulmonary Vasculature

1998

Magnetic resonance angiography (MRA) has been established as a powerful noninvasive imaging modality. Its applications to the study of the pulmonary vasculature have been hampered by a multitude of factors, such as respiratory and cardiac motion artifacts, saturation problems, long acquisition times

Noninvasive imagingmedicine.medical_specialtygenetic structuresmedicine.diagnostic_testbusiness.industryGeneral Medicineequipment and suppliesMagnetic resonance angiographyCardiac motioncardiovascular systemmedicineRadiology Nuclear Medicine and imagingPulmonary vasculatureRadiologybusinesscirculatory and respiratory physiologyInvestigative Radiology
researchProduct

Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study).

2007

Background: Trastuzumab is widely used as the treatment of choice for HER2-positive metastatic breast cancer (MBC). Patients and methods: Seventy patients, median age 57 years and range 31-81 years, were included in our retrospective analysis with the aim to evaluate safety and activity of trastuzumab-containing therapies. Results: We observed for first-line treatment response rate (RR) 41%, stable disease (SD) 47% and time to progression (TTP) 8 months (range 1-44). Corresponding numbers for second line were RR 23%, SD 62% and (TTP) 9 months (range 3-23) and beyond second line RR 22%, SD 78% and (TTP) 9 months (range 4-19). Overall survival was 19.2 months (3-62 months). The median cumulat…

OncologyAdultmedicine.medical_specialtyDrug-Related Side Effects and Adverse Reactionscardiac safety clinical experience heavily pretreated women metastatic breast cancer retrospective analysis trastuzumabAntineoplastic AgentsBone NeoplasmsBreast NeoplasmsSoft Tissue NeoplasmsAntibodies Monoclonal HumanizedAsymptomaticMetastasisBreast cancerTrastuzumabcardiac safety; clinical experience; heavily pretreated women; metastatic breast cancer; retrospective analysis; trastuzumabInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansskin and connective tissue diseasesAdverse effectneoplasmsAgedRetrospective StudiesAged 80 and overEjection fractionbusiness.industryCumulative doseAntibodies MonoclonalHematologyMiddle AgedTrastuzumabmedicine.diseaseMetastatic breast cancerSurgeryTreatment OutcomeOncologyFemalemedicine.symptombusinessmedicine.drugAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

The clinical impact of donor-specific antibodies in heart transplantation.

2018

Donor-specific antibodies (DSA) are integral to the development of antibody-mediated rejection (AMR). Chronic AMR is associated with high mortality and an increased risk for cardiac allograft vasculopathy (CAV). Anti-donor HLA antibodies are present in 3-11% of patients at the time of heart transplantation (HTx), with de novo DSA (predominantly anti-HLA class II) developing post-transplant in 10-30% of patients. DSA are associated with lower graft and patient survival after HTx, with one study suggesting a three-fold increase in mortality in patients who develop de novo DSA (dnDSA). DSA against anti-HLA class II, notably DQ, are at particularly high risk for graft loss. Although detection o…

OncologyGraft Rejectionmedicine.medical_specialty2747 Transplantationmedicine.medical_treatment610 Medicine & health030204 cardiovascular system & hematology030230 surgeryAntibodies03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumans10220 Clinic for SurgeryImmunoadsorptionKidney transplantationHeart transplantationTransplantationbiologybusiness.industryHazard ratioImmunosuppressionmedicine.disease10020 Clinic for Cardiac Surgerybody regionsbiology.proteinHeart TransplantationRituximabPlasmapheresisAntibodybusinessmedicine.drugTransplantation reviews (Orlando, Fla.)
researchProduct

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study

2018

Background: Chemotherapy plus 1-year trastuzumab is the standard adjuvant treatment of HER2-positive breast cancer. The efficacy of less extended trastuzumab exposure is under investigation. The short-HER study was aimed to assess the non-inferiority of 9 weeks versus 1 year of adjuvant trastuzumab combined with chemotherapy. Patients and methods: HER2-positive breast cancer patients with node-positive or, if node negative, with at least one risk factor (pT>2 cm, G3, lympho-vascular invasion, Ki-67 > 20%, age 35 years, or hormone receptor negativity) were randomly assigned to receive sequential anthracycline-taxane combinations plus 1-year trastuzumab (arm A, long) or plus 9 weeks tra…

OncologyTime FactorsAdjuvant Breast cancer Cardiac safety De-escalated treatment TrastuzumabSettore MED/06 - Oncologia MedicaReceptor ErbB-2medicine.medical_treatmentAnthracycline030204 cardiovascular system & hematologyBreast cancerAntineoplastic Agents ImmunologicalErbB-20302 clinical medicineTrastuzumabAntineoplastic Combined Chemotherapy ProtocolsClinical endpointAnthracyclinesskin and connective tissue diseasesAdjuvantMastectomyAdjuvant; Breast cancer; Cardiac safety; De-escalated treatment; Trastuzumab;Hazard ratioHematologyMiddle AgedChemotherapy regimenBridged-Ring CompoundImmunologicalLocalOncologyChemotherapy Adjuvant030220 oncology & carcinogenesisFemaleTaxoidsTrastuzumab adjuvant breast cancer cardiac safety de-escalated treatmentBreast NeoplasmMastectomyHumanReceptormedicine.drugAdultBridged-Ring Compoundsmedicine.medical_specialtyTime FactorSocio-culturaleBreast NeoplasmsAntineoplastic AgentsDe-escalated treatmentDisease-Free SurvivalDrug Administration Schedule03 medical and health sciencesBreast cancerTaxoidInternal medicinemedicineHumansChemotherapyRisk factorAgedNeoplasm StagingChemotherapyAntineoplastic Combined Chemotherapy ProtocolCardiac safetybusiness.industryTrastuzumabAdjuvant; Breast cancer; Cardiac safety; De-escalated treatment; Trastuzumab; Hematology; Oncologymedicine.diseaseCardiotoxicityNeoplasm RecurrenceNeoplasm Recurrence LocalbusinessAnnals of Oncology
researchProduct

Lights and shadows of cardiac magnetic resonance imaging in acute myocarditis

2016

Cardiac magnetic resonance (CMR) is considered a primary tool for the diagnosis of acute myocarditis, due to its unique potential for non-invasive identification of the various hallmarks of the inflammatory response, with relevant impact on patient management and prognosis. Nonetheless, a marked variation in sensitivity and negative predictive value has been reported in the literature, reflecting the intrinsic drawbacks of current diagnostic criteria, which are based mainly on the use of conventional CMR pulse sequences. As a consequence, a negative exam cannot reliably exclude the diagnosis, especially in patients who do not present an infarct-like onset of disease. The introduction of new…

Opinionmedicine.medical_specialtyacute myocarditis; cardiac magnetic resonance; Lake Louise criteria; T1 mappingDisease030204 cardiovascular system & hematologycardiac magnetic resonance030218 nuclear medicine & medical imaging03 medical and health sciencesacute myocarditis0302 clinical medicineCardiac magnetic resonance imagingNuclear Medicine and ImagingAcute myocarditimedicineRadiology Nuclear Medicine and imagingIn patientSettore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIANeuroradiologymedicine.diagnostic_testbusiness.industryInterventional radiologyT1 mappingAcute myocarditis; Cardiac magnetic resonance; Lake Louise criteria; T1 mapping; Radiology Nuclear Medicine and ImagingAcute myocarditisLake Louise criteriacardiovascular systemDiffuse diseaseRadiologyRadiologyCardiac magnetic resonancebusinessInsights into Imaging
researchProduct

Portable two-channel PPG cardiovascular sensor device

2003

A portable sensor device for simultaneous detection and processing of skin-remitted optical signals from any two sites of the body has been developed and tested. The photoplethysmography (PPG) principle was applied to follow the dilatation and contraction of skin blood vessels during the cardiac cycle. The newly developed two-channel approach allows to estimate the vascular blood flow resistance by analysis of time shifts between the PPG pulses detected at different body sites. Potential of the sensor device for express-assessment of human cardio-vascular condition and for body fitness tests has been demonstrated.

Optical diagnosticsCardiac cyclebusiness.industryPhotoplethysmogramMedicinesense organsBlood flowbusinessBiomedical engineeringSPIE Proceedings
researchProduct

Effectiveness of Distance Technology in Promoting Physical Activity in Cardiovascular Disease Rehabilitation : Cluster Randomized Controlled Trial, A…

2021

BackgroundPhysical activity is beneficial for cardiovascular rehabilitation. Digitalization suggests using technology in the promotion of physical activity and lifestyle changes. The effectiveness of distance technology interventions has previously been found to be similar to that of conventional treatment, but the added value of the technology has not been frequently studied. ObjectiveThe aim of this pilot study was to investigate whether additional distance technology intervention is more effective in promoting physical activity than non-technology–based treatment in 12 months of cardiac rehabilitation. MethodsThe cardiovascular disease rehabilitation intervention consisted of three 5-day…

Original Paperexerciseclinical trialetäpalvelutsatunnaistetut vertailukokeetrehabilitationcardiovascular diseasescardiac rehabilitationtechnologyrandomized controlled trialMedical technologysydän- ja verisuonitauditkliiniset kokeetkuntoutusR855-855.5teleterveydenhuoltolääkinnällinen kuntoutusfyysinen aktiivisuusliikuntahoito
researchProduct

Polycyclic Aromatic Hydrocarbons Phenanthrene and Retene Modify the Action Potential via Multiple Ion Currents in Rainbow Trout Oncorhynchus mykiss C…

2019

Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous contaminants in aqueous environments. They affect cardiovascular development and function in fishes. The 3-ring PAH phenanthrene has recently been shown to impair cardiac excitation-contraction coupling by inhibiting Ca2+ and K+ currents in marine warm-water scombrid fishes. To see if similar events take place in a boreal freshwater fish, we studied whether the PAHs phenanthrene and retene (an alkylated phenanthrene) modify the action potential (AP) via effects on Na+ (INa ), Ca2+ (ICaL ), or K+ (IKr , IK1 ) currents in the ventricular myocytes of the rainbow trout (Oncorhynchus mykiss) heart. Electrophysiological characteristics of myo…

PAH-yhdisteetHealth Toxicology and MutagenesiscardiotoxicityAction Potentialstoksikologia010501 environmental sciences01 natural sciences03 medical and health scienceschemistry.chemical_compoundmode of actionEnvironmental ChemistryMyocyteAnimalsaquatic toxicologyMyocytes CardiacPatch clampPolycyclic Aromatic HydrocarbonsMode of actionIon channelkalat030304 developmental biology0105 earth and related environmental sciencesvesistöt0303 health sciencesRetenebiologyPhenanthrenePhenanthrenesAryl hydrocarbon receptorhiilivedytchemistryReceptors Aryl Hydrocarbonpolycyclic aromatic hydrocarbons (PAHs)Oncorhynchus mykissbiology.proteinBiophysicsRainbow troutWater Pollutants ChemicalEnvironmental toxicology and chemistry
researchProduct